Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Neuroendocrine Tumors 11Neoplasms 8Carcinoid Tumor 7Diarrhea 6Colorectal Neoplasms 6Carcinoma, Hepatocellular 5Vipoma 4Stomach Neoplasms 4Somatostatinoma 4Rectal Neoplasms 4Insulinoma 4Glucagonoma 4Gastro-enteropancreatic neuroendocrine tumor 4Carcinoma, Islet Cell 4Breast Neoplasms 4Adenoma, Islet Cell 4Acromegaly 4Weight Loss 3Prostatic Neoplasms 3Pancreatic Neoplasms 3Neoplasm Metastasis 3Intestinal Obstruction 3Gastrinoma 3Esophageal Neoplasms 3Colonic Neoplasms 3Carcinoma 3Thymoma 2Pituitary Neoplasms 2Ovarian Neoplasms 2Meningioma 2

Interventions

Magnetic Resonance Spectroscopy 16Hydroxyurea 7Everolimus 7Bevacizumab 7lutetium Lu 177 dotatate 6gallium Ga 68 dotatate 6Proton Therapy 6Specimen Handling 5pembrolizumab 4Surgical Procedures, Operative 4Radiosurgery 4Imatinib Mesylate 4Cyclophosphamide 42-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 4aldesleukin 3abemaciclib 3Tranexamic Acid 3Temozolomide 3Sunitinib 3Sodium Chloride 3Radiotherapy, Intensity-Modulated 3Radiotherapy 3Nivolumab 3Ga(III)-DOTATOC 390Y-octreotide, DOTA-Tyr(3)- 3vistusertib 2trametinib 2ribociclib 2fludarabine 2arginyllysine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Meningioma × Octreotide × Clear all
NCT06326190 2025-09-16

LUMEN-1

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Recruiting
136 enrolled
CNS

Meningioma

NCT02333565 2023-05-25

CEVOREM

Assistance Publique Hopitaux De Marseille

Phase 2 Completed
20 enrolled
CNS

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡